← All organizations

Highest phase reached
Phase 1
First clinical trial
Jun 20, 2019Last known activity
Nov 5, 2024
Timeline
2010s
- Jun 1, 2010
Emalex Biosciences— Founded
- Aug 14, 2018
Psyadon Pharma— Acquired
Drugs by trial phase (6 distinct, 20 trials)
Phase 3 (0 own, 1 via acquisition)
Phase 1 (4 own, 1 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (17)
- NCT07093541OfficialN/A—
- NCT07093541Lead sponsorN/A—
- NCT06669091Lead sponsorPhase 1Nov 5, 2024
- NCT06669091OfficialPhase 1Nov 5, 2024
- NCT06194864OfficialPhase 1Jan 18, 2024
- NCT06194864Lead sponsorPhase 1Jan 18, 2024
- NCT06021522Lead sponsorPhase 3Aug 16, 2023
- NCT05841160Lead sponsorPhase 1Mar 15, 2023
- NCT05615220Lead sponsorPhase 3Dec 31, 2022
- NCT05334108Lead sponsorPhase 1Apr 26, 2022
- NCT04902105Lead sponsorPhase 1May 13, 2021
- NCT04881955Lead sponsorPhase 1May 12, 2021
- NCT04764851Lead sponsorPhase 1Feb 18, 2021
- NCT04492956Lead sponsorPhase 2Oct 2, 2020
- NCT04492956Study directorPhase 2Oct 2, 2020
Details
- Founded
- Northbrook, IL, US Jun 1, 2010
- Last known activity
- Nov 5, 2024